The positive effects of glioblastoma-derived EVs on proliferation and migration of NPCs were further abrogated when recipient cells were treated with Wortmannin, a PI3K inhibitor [19], which, confirmed PI3K-Akt pathway as an essential downstream factor of aforementioned EVs. This evidence concerns the gene AKT1 and glioblastoma.